biomedicina slovenica

re="Eur J Cancer Suppl" : 31

  1. Kenig S; Majdič T; Duran-Alonso MB; Lah T
    Endothelial cells increase invasiveness of glioblastoma cells and protect them from apoptosis
    2010 ►
  2. Ravnik M; Snoj N; Sadikov A; Nussdorfer P; Čufer T
    Comparison of adjuvant! Online prediction with 10-year follow-up results according to the uPA and PAI-1 levels in Slovenian early breast cancer patients
    2010 ►
  3. Ravnik Maja; Takač Iztok; Arko Darja; Gorišek Borut; Čas-Sikošek Nina; Lampelj Maja; Ravnik Janez; Čufer Tanja
    Expression of invasive markers (uPA/PAI-1) in four different HER2, ER, PR subgroups of early breast cancer
    2008 ►
  4. Marty Michel; Serša Gregor; Snoj Marko; Miklavčič Damijan; Pavlović Ivan; Paulin-Košir Marija Snežna; Čemažar Maja; Rudolf Zvonimir
    Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases : results of ESOPE (European standard operating procedures of electrochemotherapy) study
    2006 ►
  5. Snoj Marko; Rudolf Zvonimir; Paulin-Košir Marija Snežna; Čemažar Maja; Snoj Rudolf; Serša Gregor
    Long lasting complete response in melanoma treated by electrochemotherapy
    2006 ►
  6. Serša Gregor
    The state-of-the-art of electrochemotherapy before the ESOPE study : advantages and clinical uses
    2006 ►
  7. Mir Lluis Maria; Gehl J; Serša Gregor; Collins Christopher G.; Garbay JR; Billard Valérie; Geertsen PF; Rudolf Zvonimir; O'Sullivan Gerald C; Marty Michel
    Standard operating procedures of the electrochemotherapy : instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator TM by means of invasive or non-invasive electrodes
    2006 ►
  8. Jelen-Jurič J; Prijatelj B; Lokar K
    Advanced course for nurses as the first step towards quality improvement of vascular access port management
    2005 ►
  9. Globokar T; Snoj Nataša; Sadikov A; Čufer T
    Amenorrhea as a prognostic factor in premenopausal endocrine responsive early breast cancer patients
    2006 ►
  10. Snoj Nataša; Globokar T; Sadikov A; Čufer T
    Correlation between hormonal receptor levels and efficacy of hormonal therapy and chemotherapy in metastatic breast cancer
    2006 ►
  11. Lokar K
    The knowledge of young men about testicular cancer and their attitudes toward it
    2001 ►
  12. Strojan P; Zakotnik B; Šmid L; Karner K; Šoba E
    Concomitant radiochemotherapy with Mitomycin C and Cisplatin in inoperable carcinoma of the head and neck: preliminary results of phase II study
    2005 ►
  13. Oblak I; Strojan P; Gale N; Mid L
    Expression of cystein proteases cathepsin B in inoperative squamous cell carcinoma of the head and neck
    2005 ►
  14. Skela-Savič B; Strojan P; Lokar K
    Identification of the needs for organized palliative care in radiation oncology
    2005 ►
  15. Garbay JR; Serša G; O'Sullivan GC; Gehl J; Cadossi R; Mir L
    Results of the ESOPE multicentre study on electrochemotherapy
    2005 ►
  16. Rudolf Z; Serša G; Gehl J; O'Sullivan GC; Garbay JR; Cadossi R; Mir LM
    Indications for treatment by electrochemotherapy; results of the ESOPE European trials
    2005 ►
  17. Lokar K; Skela-Savič B
    Quality management in patient care at the Institute of oncology Ljubljana
    2005 ►
  18. Paridaens R; Therasse P; Dirix L; Beex L; Piccart MJ; Cameron D; Čufer T; Roozendael K; Nooy M; Mattiacci MR
    First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) - EORTC 10951 in collaboration with the exemestane working group and NCIC clinical trials group
    2004 ►
  19. Matos E; Borstnar S; Vrhovec I; Svetič B; Čufer T
    PAI-1 and PAI-2 as predictive factors in breast cancer
    2004 ►
  20. Drev P; Golouh R; Snoj Nataša; Čufer T
    Correlation between Her-2 status in primary tumour and response to anastrozole in patients with metastatic breast cancer
    2004 ►
  21. Pajk B; Borštnar S; Snoj Nataša; Čufer T
    Disease free survival (DFS) in breast cancer patients older than 70 years compered to younger patients groups
    2004 ►
  22. Paridaens R; Dyczka J; Rutgers EJT; Coleman R; Čufer T; Jassem J; Nortier JRW; Morales L; Mattiacci MR; Therasse P; Gasthuisberg UZ
    Postoperative adjuvant chemotherapy folowed by adjuvant tamoxifen versus nil for patients with operable breast cancer. First results of a randomized phase III trial EORTC 10901
    2004 ►
  23. Snoj Nataša; Pajk B; Borštnar S; Čufer T
    The benefits of adjuvant hormonal therapy in patients with early breast cancer 35 years old or younger
    2004 ►
  24. Piškur P; Sonc M; Čufer T; Borštnar S; Mrhar A
    Pharmacoeconomics aspects of adjuvant early breast cancer treatment in postmenopausal women with anastrozole or tamoxifen: a Slovenian perspective
    2004 ►
  25. Podkrajšek M; Hertl K; Hočevar M; Žgajnar J; Bešić N; Bračko M
    Axillary ultrasound (US) and US-guided fine needle aspiration biopsy in the assessment of lymph-node metastases in breast cancer patients
    2003 ►
  26. Velepič M; Skela-Savič B; Koren P
    An impact of internal quality control in oncology nursing care
    2003 ►
  27. Strojan P; Svetic B; Šmid L; Kos J
    Cysteine proteinase inhibitor cystatin C (CC) in operable squamous cell carcinoma of the head and neck (SCCHN): expression pattern and relation to prognosis
    2003 ►
  28. Oblak I; Strojan P; Zakotnik B; Budihna M; Šmid L
    Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy
    2003 ►
  29. Bešić N; Žgajnar J; Bergant D; Hočevar M; Pompe F
    Prognostic factors in follicular and Huerthle cell carcinoma of the thyroid gland - a multivariate survival analysis
    2003 ►
  30. Bergant D; Glavač D; Bešić N; Hočevar M
    Medullary thyroid carcinoma (MTC): genetic screening in Slovenia 1997-2002
    2003 ►
  31. Snoj M; Vidergar-Kralj B
    Added value of blue dye in sentinel node biopsy for breast cancer
    2003 ►

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko